FDA allows more pharmacists to prescribe Pfizer COVID antiviral Paxlovid

Rafmaster/iStock via Getty Images

• More pharmacists now have the ability to directly prescribe Pfizer's (NYSE:PFE) COVID-19 antiviral Paxlovid in certain situations.
• The U.S. FDA has amended the Emergency Use Authorization for Paxlovid (nirmatrelvir and ritonavir) to allow state-licensed pharmacists to prescribe the treatment based on evidence of a positive COVID test.
• Patients should bring electronic or printed health records as well as the list of medications they are taking for a pharmacist to review.
• The federal government already has the Test to Treat initiative in many pharmacies across the country that provides free testing and filling of an antiviral prescription at the same time. Many CVS Health (CVS) locations are part of this initiative.
• The change is aimed at having smaller, community pharmacies provide easier access to COVID antivirals.
• In late June, Pfizer (PFE) filed a New Drug Application with the FDA seeking full approval of Paxlovid.

Comments

[MickeyD77]

I wonder if this will also allow use of the Merck drug for Covid. It seems to have fewer drug interactions and is being used more frequently than the Pfizer drug.

[mo’ widgets]

Did Pfizer approved of this FDA decision?

[6824615]

There are criteria in order to get prescribed and if you qualify and of course your physician writes prescription it is a worthy option to consider. Hats off to the entire medical community (particularly Pfizer, Medicare, CVS) for outstanding work and availability. U.S. is so far ahead in CV19 treatments and overall network battling a disease that will be with us longer than we previously thought. Keep in home test kits available and do your due diligence by researching options in treating early onset of disease. Good luck to all.